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INTRODUCTION 
Patent ductus arteriosus (PDA) is a common cause of 
morbidity and mortality among preterm infants that 
involved more than 40 % of them. There are several 
diseases that can be associated with PDA but it is not clear 
whether PDA has role in their producing or not.1,2 PDA 
treatment includes medical and surgical methods. Most of 
drugs  are used  to  closure of  PDA   such  as  ibuprofen  
and  indomethacin that often cyclo-oxygenase  inhibitors  
that  inhibit  the  conversion  of  arachidonic  acid  to  
prostaglandin.3,4 The  success  rate  of  PDA  treatment  
with  Ibuprofen  has  been  reported  in various  studies in 
the  range  of  70-85%.5-8 Several  complications  include  
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ABSTRACT 
Background: Patent ductus arteriosus (PDA) is a common cause of morbidity and mortality among premature infants 
that affects more than 40% of them. PDA treatment includes medical and surgical treatment. Most drugs used to block 
PDA are cyclooxygenase inhibitors (ibuprofen and indomethacin). The role of paracetamol as an alternative therapy in 
PDA ligation has been considered in recent years due to the potential side effects of cyclooxygenase inhibitors. 
Methods: Patients in the first group were treated with intravenous paracetamol at a dose of 15 mg/kg every 6 hours for 
three days and the second group was treated with intravenous ibuprofen at a daily dose of 10 mg/kg daily and 5 mg/kg 
for the second and third days. At the end of the treatment period (day 3), they underwent echocardiography again. If the 
echocardiographic findings indicated no closure of the arterial duct, patients were treated with the aforementioned drug 
for another period and rechecked at the end of the third day, and at each stage required information was collected. 
Results: Arterial duct closure in paracetamol group was 96.7% and in ibuprofen group was 100%. The effects of both 
paracetamol and ibuprofen were similar in terms of renal parameters but in terms of effects on liver parameters. The 
effect of paracetamol on all liver parameters except aspartate transaminase (AST) was significant, but ibuprofen was 
able to affect only bilirubin among liver parameters and had no significant effect on both AST and alanine 
aminotransferase, parameters. 
Conclusions: Results showed that both paracetamol and ibuprofen are effective in treating of PDA and had similar 
impact. 
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peripheral  vaso-constriction, gastrointestinal  bleeding  
and   perforation, decreased  platelet  association, 
hyperbilirubinemia  and  kidney   failure  have  been  
reported  in  these  patients.9-12 
In  recent  years  the  role  of  paracetamol  (acetaminophen)  
as  an  alternative  treatment  in  closure of PDA due  to  
the  potential  effects  of  cyclooxygenase    inhibitors  has  
been  considered.13-15 Some  studies  have  shown  that  
intravenous  paracetamol  can  be replaced in patients  with  
contraindication for  given  ibuprofen prescription.15 If 
non-steroidal anti-inflammatory drug (NSAID)   are  not  
successful  in the treatment of PDA  treatment  or  NSAID   
are  controandice,  the  only available way was surgery that 
this surgery associated with risk  of  cardiothoracic  
surgery  and  neurologic  complications.16 Therefore   
another  drug  intervention  is  needed. The aim of this 
study was to compare of the effect of two drugs 
paracetamol with intravenous ibuprofen in treatment of 
PDA.  
METHODS 
Study design and participants  
This is a single-blind clinical trial that has been done from 
April 2018 to 2019 on 60 preterm infants with gestational 
age of 34-34 weeks who hospitalized in the NICU of 
Ardabil Bu-Ali and Alavi hospitals which have confirmed 
PDA in echocardiography. 
Inclusion and exclusion criteria  
 Infants with life-threatening infections, with a urinary 
output of less than 1 ml/kg/h over the past 8 hours, with 
serum creatinine levels above 1/88. 4 um, with platelet 
count less than 50000 per liter, hyperbilirubinemia 
requiring blood exchange, active necrotizing enterocolitis, 
liver dysfunction, retinopathy, gastrointestinal bleeding   
and parental dissatisfaction were excluded from the study.   
Data collection and sampling technique 
Patients were randomly divided into two groups each with 
30 infants. Patients in the first group were treated with 
intravenous paracetamol at a dose of 15 mg/kg every 6 
hours for three days and the second group was treated with 
intravenous ibuprofen at   initial dose of 10 mg/kg daily 
and the second and third days were 5 mg/kg. All infants go 
to echocardiography 24 hours later and if the 
echocardiography findings indicated no closure of the 
PDA, patients were treated with the drug for another 
period and rechecked by ECG at the end of the third day. 
Required information were recorded and collected at each 
stage. Complete blood count (CBC), bilirubin (Bili), blood 
urea nitrogen (BUN), creatinine (Cr), aspartate 
transaminase (AST), alanine aminotransferase (ALT), and 
cranial   ultrasound examinations were performed before 
and 24 hours after drug administration and results were 
recorded in a checklist.  
Statistical analysis  
Data were analyzed by SPSS version 24 and T- test was 
used for relation between quantitative data and chi-square 
test for relation between qualitative data. Significance 
level was considered at less than 0.05 in all tests.  
RESULTS 
In this study, 50 % of the samples were girls and 50 % were 
boys. The lowest gestational age was 28 and the highest 
was 34 from and the age of neonates were from 1 to 3 days 
and the two groups were similar in terms of age. The size 
of the initial PDA varied from 1.3 to 4 mm. 
Echocardiographic examination showed that PDA was 
100% closed in the biboprofen group and 96.7% in the 
paracetamol group and the effect of both drugs on PDA 
closure was found to be same. Gastrointestinal bleeding 
complications were not observed in two groups. Cranial 
ultrasound was normal in both groups. There were no 
significant differences between the renal function indices 
before treatment and the first 24 hours after treatment 
among two groups (Table 1). 
Regarding the changes in liver function indices before and 
also in the first 24 hours after treatment, it was found that 
there was no significant difference between the two groups 
and we could say that administration of either paracetamol 
or ibuprofen has not effects on neonatal liver function 
indices (Table 2). 
Independent T-test show no significant changes in platelet 
level between the two groups before and after treatment 
(Table 3). 
Results showed that in the paracetamol group, the platelet 
content decreased after treatment compared to pre-
treatment and in the ibuprofen group, platelet content 
increased but the difference was not statistically 
significant in two groups (Table 4).  
Table 1: The amounts of renal performance indices in 
two groups. 
Renal 
indices  
Groups Mean±SD P value 
Cr before 
24 hours 
Paracetamol 0.74±0.19 
0.68 
Ibuprofen 0.78±0.4 
Cr later 24 
hours 
Paracetamol 0.6±0.2 
0.57 
Ibuprofen 0.6±0.3 
BUN 
before 
Paracetamol 22.3±9.8 
0.06 
Ibuprofen 28.5±14.6 
BUN 24 
hours later 
Paracetamol 19.5±8.4 
0.28 
Ibuprofen 22±9.5 
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Table 2: The amounts of liver performance indices in 
two groups. 
Liver 
indices  
Groups Mean±SD P value 
Bilirubin 
before 
Paracetamol 8.3±1.8 
0.28 
Ibuprofen 7.8±2.2 
Bilirubin 24 
hours later 
Paracetamol 7.3±1.1 
0.37 
Ibuprofen 6.9±1.9 
AST before 
Paracetamol 42.6±9.7 
0.71 
Ibuprofen 43.8±14.2 
AST 24 
hours later 
Paracetamol 40.8±10.6 
0.69 
Ibuprofen 41.9±11.4 
ALT before 
Paracetamol 16±3.8 
0.26 
Ibuprofen 17.9±7.8 
ALT 24 
hours later 
Paracetamol 14.9±4.2 
0.18 
Ibuprofen 16.9±6.9 
Table 3: The amounts of platelet in two groups. 
Time Groups Mean±SD P value 
Before 
Paracetamol 285300±39270 
0.08 
Ibuprofen 259640±66754 
24 hours 
later 
Paracetamol 273700±30315 
0.38 
Ibuprofen 289280±92760 
 
Results showed that among paracetamol recipients the rate 
of changes in Cr/BUN/bilirubin/ALT after treatment   
significantly higher than before but for the AST index 
these changes were not significant (Table 5). 
Results showed that among ibuprofen recipients, the rate 
of BUN/Cr/Bili changes after treatment was significantly 
higher than before but for ALT and AST indices this 
difference was not significant (Table 6).  
 
Table 4: The changes of platelet indices in two groups by time. 
Drugs Groups Mean±SD Mean diff P value 
Paracetamol 
Before 285300±39270 
11600 0.12 
24 hours later 273700±30315 
Ibuprofen 
Before  259640±66754 
-29620 0.08 
24 hours later  289280±92760 
Table 5: The changes of experimental indices in paracetamol group by time. 
Indices Groups Mean±SD Mean diff P value 
Cr        
Before 0.74±0.19 0.14 0.001 
24 hours later 0.6±0.2 
BUN    
Before  22.3±9.8 2.8 0.001 
24 hours later  19.5±8.4 
Bili       
Before 8.3±1.8 0.5 0.002 
24 hours later 7.8±2.2 
AST     
Before 42.6±9.7 1.8 0.07 
24 hours later 40.8±10.6 
ALT     
Before 16±3.8 1.1 0.016 
24 hours later 14.9±4.2 
Table 6: The changes of experimental indices in ibuprofen group by time. 
Indices Groups Mean±SD Mean diff P value 
Cr        
Before 0.78±0.4 
0.18 0.001 
24 hours later 0.6±0.3 
BUN    
Before  28.5±14.6 
6.5 0.005 
24 hours later  22±9.5 
Bili       
Before 7.8±2.2 
0.9 0.008 
24 hours later 6.9±1.9 
AST     
Before 43.8±14.2 
1.9 0.3 
24 hours later 41.9±11.4 
ALT     
Before 17.9±7.8 
1 0.11 
24 hours later 16.9±6.9 
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DISCUSSION 
The arterial canal is functionally closed in most term 
neonates on the first day of life and PDA is permanently 
abnormal.  
Since  30-60%  of  infants  with low  birth  weight, arterial 
canal remain open and spontaneous  occlusion  of  this  
artery  occurs  only  in  one  third  of  infants with less  than  
1000 g  in  the  first  four  days  of  life , therefore   a 
significant  majority  of  these  infants  are  potential  
candidates  for  drug  or  surgical  interventions.17 One  of  
the  important  topics  in  neonatal  science  is  arterial  
closure methods.  The findings of a recent study showed 
that the results of using oral acetaminophen were 
comparable to ibuprofen in PDA and both drugs had 
similar effect in PDA in preterm infants. Although the use 
of drugs such as indomethacin and ibuprofen are common 
medications but the side-effects and barriers to their use 
have always been of interest to experts in finding less 
effective drug therapies. So far, few studies have been 
conducted to evaluate the efficacy of ascetaminophen in 
the treatment of open artery and compare its efficacy with 
other drugs. In many cases, acetaminophen is also used as 
a complementary drug not as a first-line treatment in cases 
where COX inhibitors are ineffective or contraindicate has 
for their using. In the present study, there was no 
significant difference between the effect of intravenous 
ibuprofen and intravenous acetaminophen on PDA in 
preterm infants. The results of Dang et al study which 
compared the efficacy and safety of oral acetaminophen 
versus oral ibuprofen on 160 preterm infants (with 
gestational age less than 34 weeks) showed that both drugs 
were treated equally in the PDA (81.2% vs. 78.8%). These 
results are consistent with the findings of our study.18 
Results  of  evaluation  of  efficacy  and  safety  of  oral  
Acetaminophen  versus  oral  Ibuprofen  for  the  treatment  
of  PDA in  90  premature  infants with gestational  age 
less  than  30  weeks  and  birth  weight  less  than  1250  g 
, which  their PDA confirmed by ECG, showed  that  after  
the  first  treatment  period,  the  PDA was  closed  in  
77.5%  of  neonates  receiving  Ibuprofen  and  72.5%  of  
neonates  receiving  acetaminophen . The  researchers  
concluded  that  oral  acetaminophen  could  be  a good  
alternative  to  the  treatment  of  PDA in  premature  
infants.19 Based  on  the  study  by  Sinha et  al as  well  as  
the  study  by  Trerien  et  al  acetaminophen, compared  to  
ibuprofen  can  be  a safe  and  promising  drug  for  the  
treatment  of  PDA in  premature   infants with PDA.20-21 
Yorotouten  et  al  also  evaluated  and  treated  six  
premature  infants  with PDA with  oral  Acetaminophen  
suggesting  that  acetaminophen has  the  low  side  effects 
and low  cost  and  had efficacy than other drugs in 
treatment of PDA. This  result  is  also  in  line  with  the  
findings  of  our  study.22 A study  conducted  at  Qazvin  
university  of  medical  sciences  in  2007  aimed  to  
compare  the  effect  of  oral  ibuprofen  with  oral  
acetaminophen  on  the  closure  of  PDA in  preterm  
infants  also  suggested  paracetamol  as  a suitable  
alternative  to  ibuprofen.17 Zasel  et  al  also  concluded  
that  there  was  no  significant  difference  between  the  
two  drugs  paracetamol  and  ibuprofen  in  the PDA 
treatment.23 Overall,  paracetamol  seems  to  be  a good  
alternative  to  ibuprofen. According to the results of this 
study, there was no gastrointestinal bleeding and platelet 
loss induced by ibuprofen. According  to  a study  by  Dung  
et  al which  compared  the  efficacy  and  safety  of  oral  
acetaminophen  versus  oral  Ibuprofen  in  160  premature  
infants  (with gestational age less  than  34  weeks),  
hyperbilirubinemia or  gastrointestinal  bleeding  in  the  
acetaminophen  group  was  somewhat  lower than 
ibuprofen.18 In  this  study,  no  differences  were  found  
in  other  side  effects or  problems  between  the  two  
groups. According  to  the  results of  the  study  by  Sinha  
et  al  unlike  Ibuprofen which  had many side  effects,  no  
side  effects were  observed after  oral  acetaminophen 
administration.20 According to the results of the study by 
Treiean et  al although neonatal  treatment  with  ibuprofen  
or  indomethacin  produced  many  adverse  effects but no  
adverse  effects  or  serious  problems  were  observed  
during  treatment with  acetaminophen. The results of these 
studies were similar to our study results.21  
CONCLUSION 
Results showed that PDA closure rate was higher in 
ibuprofen recipients’ groups (100%) than in paracetamol 
recipients (96.7%) but this difference was not statistically 
significant. We could say that both ibuprofen and 
paracetamol drugs were effective in treating PDA and can 
be used interchangeably. Gastrointestinal bleeding and 
platelet loss were not observed in this study among two 
groups. It is suggested that a larger sample size study be 
conducted in other centers and provinces in the future. 
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